The involvement of CD4+ T lymphocytes in the defense mechanisms against intracellular pathogens is widely recognized. Little information is available on the generation and specificity of the cytotoxic cells that eliminate human monocytes/macrophages infected with mycobacteria. In this work, we tested whether mononuclear cells from leprosy patients could generate cytotoxic T-cell activity against autologous macrophages pulsed with Mycobacterium leprae or purified protein derivative (PPD) in a 4-h 5"Cr release assay. Peripheral blood mononuclear cells from normal Mycobacterium bovis BCG-immunized controls or from leprosy patients stimulated with antigen for 7 days were used as effector cells. Paucibacillary (PB) patients and normal controls yielded more active effector cells in this system than multibacillary (MB) patients. MB patients were able to develop cytotoxicity against M. Ieprae, BCG, or PPD, in contrast with the immunological anergy widely described. We did not find cytotoxicity against unpulsed macrophages. Cross-reactivity was observed between PPD, BCG, and M. Ieprae. Only antigen-pulsed autologous macrophages were suitable as target cells. M. kprae-induced cytotoxic cells were found in both CD4+ CD8-and CD4-CD8+ T-cell subsets, whereas CD4+ cells were the main component of PPD-induced cytotoxicity. In MB patients, BCG-induced cytotoxic cells were better killers of M. Leprae-pulsed macrophages than cells induced by M. leprae. This is an interesting finding in view of the ongoing vaccination trials. The involvement of CD4-or CD8-mediated cytotoxicity may be important in the balance between protection and tissue or nerve damage.
Leprosy is a chronic infectious disease caused by infection with Mycobacterium leprae. The clinical forms strongly correlate with the degree of cell-mediated immunity. Most studies have emphasized the role of regulatory T cells, mainly those of the CD4 T-helper phenotype, in the generation of immunological resistance to these intracellular microorganisms (1) . Patients with tuberculoid leprosy develop high levels of cell-mediated immune response, and their granulomatous lesions are typical of delayed-type hypersensitivity and are composed of well-differentiated macrophages and epithelioid cells with few bacilli, associated with a large number of CD4+ T cells and surrounded by CD8+ T cells (27, 28, 35, 40) . Lepromatous leprosy patients are a model of antigen-specific T-cell nonresponsiveness that can be overcome in vitro only in some cases by the addition of exogenous lymphokines (15, 34) or by stimulation with fractionated M. leprae components (33) . Their lesions are composed of macrophages loaded with M. leprae, closely associated with scarce CD4+ suppressor/inducer lymphocytes and mainly consisting of CD8+ suppressor/cytotoxic cells (27, 28, 40) .
In the paucibacillary (PB) form of leprosy, parasitized and foamy macrophages and epithelioid cells are destroyed in association with highly polarized lymphocytes of an unknown phenotype (20, 21) ; more recently, a similar pattern has been observed in lepromatous lesions after the intradermal injection of gamma interferon (30) , purified protein derivative (PPD) (20) , interleukin-2 (19) , and mixtures of M. * Corresponding author. leprae or M. lepraemurium with Mycobacterium bovis BCG (6) in the lesions. Under these conditions, infected macrophages release large numbers of M. leprae and parasitized macrophages are destroyed by newly immigrated mononuclear cells, including CD4+ and CD8+ T cells, monocytes, and T6+ Langerhan's cells (18) . It has become increasingly clear that acquired resistance against intracellular bacteria, such as M. tuberculosis, M. bovis, and M. africans, crucially depends on the activation of mononuclear phagocytes by specific T lymphocytes (5, 6, 13, 26) . Antigen-specific lysis of macrophages harboring the bacteria may be important not only for the elimination of the bacterial reservoir but also for the induction of immunopathological lesions that are prevalent in leprosy and tuberculosis. Mustafa and Godal (29) have demonstrated induction of cytotoxic T cells from primed peripheral blood mononuclear cells (PBMC) of BCGvaccinated healthy controls capable of killing BCG-pulsed macrophages. Hancock et al. (14) have observed the development of cytotoxic cells against primed macrophages after exposure of effector (E) and target (T) cells to PPD or tetanus toxoid. The nature of the interaction between cytotoxic T cells and infected macrophages is one of considerable interest for all intramacrophage parasites, such as Leishmania species (38) .
In the present work, we studied the ability of PBMC cells isolated from leprosy patients to generate cytotoxic cell activity against autologous macrophages previously pulsed with different mycobacterial antigens. Blockade of effector cells by anti-CD4 or anti-CD8 MAbs. To explore the involvement of these T-cell subsets in the induction phase, we incubated PBMC (107 cells resuspended in 50 ,ul of RPMI 1640) with anti-CD4 or anti-CD8 monoclonal antibodies (MAbs) (20 ,ug/ml) (Leu3a and Leu2a MAbs, respectively; Becton Dickinson) for 1 h at 37°C. The cells were then washed three times, resuspended in complete medium at 2 x 106 cells per ml, and incubated for 7 days with or without antigens as described above.
MATERIALS AND METHODS

Patients
To determine the role of CD4 and CD8 molecules in the effector phase of the assay, we incubated effector cells that were recovered from the 7-day cultures (5 x 106/ml) with anti-CD4 or anti-CD8 MAbs (10 ,ug/ml) for 1 h at 37°C. The cells were then washed three times and used in the cytotoxicity assay as described above. The proportion of CD4 and CD8 cells was studied by using a standard immunofluorescence technique with anti-CD4 and anti-CD8 MAbs (36) . Fig. 1A shows the levels of M. leprae-induced cytotoxicity against M. leprae-pulsed autologous macrophages. N controls and PB patients presented higher cytotoxicity than MB patients at all E/T ratios tested. When PPD was used as the antigen to induce cytotoxicity, a similar pattern was observed, but differences between N controls and PB patients were smaller when compared with MB patients (Fig. 1B) ; even at the 80:1 ratio, the MB response was lower than that of PB and N. PPD-induced cytotoxicity was higher than that generated when M. leprae was 4 -h cytotoxicity assay as described in Materials and Methods., Results are expressed as percent cytotoxicity (mean ± standard error) after subtracting lytic activity from cultures of primed PBMC and control macrophages. Statistical differences for PPD induced cytotoxicity against PPD-pulsed macrophages versus that against M. leprae-pulsed macrophages: MB, P < 0.01; PB, P < 0.005 (Student t test).
confirm that cytotoxic effector induction was less efficient in MB patients than in N controls against both PPD-and M. leprae-pulsed targets. The cytotoxicity of BCG-induced effector cells that recognized both PPD and M. leprae targets in MB patients and N controls was higher than that displayed by M. leprae-primed effector cells. Furthermore, in MB patients, BCG effector cells were better killers of M. leprae targets than were M. leprae effector cells (P < 0.02). Ieprae or PPD and used as effector cells as described in the text. M. leprae-or PPD-pulsed macrophages were incubated with or without anti-HLA-DR MAb for 1 h at 37'C and after three washes were used as target cells in the cytotoxicity assay.
As shown in Table 5 , blockade of PBMC with anti-CD4 MAb at the beginning of the culture abolished specific cytotoxic activity. Addition of anti-CD8 MAb to PBMC reduced the cytotoxicity of N and PB lymphocytes but to a lesser extent than the addition of anti-CD4 MAb. Reduction of cytotoxicity by blockade of T-cell subsets was difficult to assess in MB patients because of the low cytotoxic activity induced by M. leprae in this group of patients. Furthermore, blockade of the effector cells with anti-CD4 MAb after their induction with M. leprae also prevented cytotoxicity (Table  6 ). While anti-CD8 MAb reduced the response of M. lepraeprimed effector cells, it had no significant effect on PPDprimed effector cells. The inability of anti-CD8 MAb (of the same immunoglobulin Gl subclass as anti-CD4 MAb) to block PPD-elicited cytotoxicity rules out nonspecific effects of the antibodies.
DISCUSSION
The results of this study demonstrate that M. leprae is able to induce cytotoxicity of T lymphocytes from patients with leprosy and from BCG-immunized individuals against autologous macrophages that present M. leprae or related mycobacterial antigens ( Fig. 1 and Table 1 ). Lymphocytes of PB and N subjects are more active as effector cells in this system than those of MB patients. However, the cytotoxic activity of MB lymphocytes is significant and contrasts with the immunological anergy to M. leprae antigens that has been extensively demonstrated in MB patients (11, 15, 34) .
As expected, there was cross-reactivity between M. lep- a PBMC from MB patients (n = 3), PB patients (n = 4), and N controls (n = 5) were incubated with anti-CD4 or anti-CD8 MAbs for 1 h at 37°C; after three washes, they were cultured for 7 days with M. leprae and used as effector cells in the cytotoxicity assay (see Materials and Methods). Macrophages pulsed with M. leprae were used as target cells. The cytotoxicity assay was performed at a 40:1 E/T ratio. rae and PPD in the generation of cytotoxic effector cells (Fig. 2 ). An interesting finding is that the cytotoxicity against M. leprae-pulsed macrophages in MB patients was similar whether the effector cells were induced with M. leprae or PPD. Likewise, M. leprae-primed effectors were equally effective against PPD-pulsed macrophages. These results indicate that cytotoxic precursors responding to M. leprae are largely restricted toward the recognition of cross-reactive determinants. The fact that PPD-elicited MB cytotoxic effectors gave higher responses against PPD-pulsed macrophages indicates that additional antigenic determinants may be operating. Also, physical characteristics of the antigen during the induction phase could influence the results.
In PB patients, PPD-induced cytotoxicity against M. leprae-pulsed macrophages was lower than M. leprae-induced cytotoxicity against M. leprae-or PPD-pulsed macrophages, while the PPD-induced anti-PPD response was the highest. In this regard, the results obtained by using BCG induction in MB patients and N controls (Table 2) are coincident with those of PPD induction in PB patients (Figure 2 ). Moreover, BCG was relatively better as an inducer of cytotoxicity against M. leprae than M. leprae itself. This is an interesting finding, in view of the ongoing vaccination trials with BCG and killed M. leprae (7, 9, 25) .
The higher reactivity of N PPD-induced effectors against autologous M. leprae-pulsed macrophages when compared with that of leprosy patients may be due to the absence of an ongoing M. leprae infection in the control group, which could affect the distribution of M. leprae-specific cytotoxic cells in the circulation. In this regard, it is interesting that cytotoxicity of PPD-induced lymphocytes from both MB and PB patients against M. leprae-pulsed macrophages was similar in magnitude at higher E/T ratios. In a recent study by Kaleab et al. (17) , it was also shown that PBMC isolated from leprosy patients and healthy occupational contacts respond to M. leprae and BCG stimulation, yielding a cytotoxic response against autologous M. leprae-or BCGprimed macrophages. A positive correlation was established between M. leprae-or BCG-induced proliferation and cytotoxicity (17, 24) . Lymphocyte proliferation was not assessed in our study, but we were able to compare the cytotoxicity generated in 8 of our 15 MB patients with the proliferative response to M. leprae evaluated in the same patients in a previous routine study (36a), and we found a good correlation (data not shown). In contrast to the results of Kaleab et al. (17) and Kumararatne et al. (24), we did not find significant cytotoxicity against unpulsed macrophages (Fig. 1) The fact that only antigen-pulsed autologous macrophages were suitable as target cells suggested that histocompatibility antigen restriction was operating in the system (Table 3) . Because treatment of M. leprae-pulsed macrophages with anti-HLA-DR antibodies inhibited cytotoxicity, the participation of CD4+ effector cells in our system was inferred ( Table 4) . Identification of CD4+ lymphocytes as the main component of the M. leprae-induced cytotoxic cells was confirmed by the inhibitory effect of anti-CD4 both in the inducing and in the final effector phases of the assay (Tables  5 and 6 ). Participation of CD8+ cells also is demonstrated on the basis of the inhibitory effect of anti-CD8 (Table 5 (22) . Regulatory lymphokines are key elements in the control of CD4 and CD8 effector activity, and there are suggestions about a relative predominance of Thl-like cells in tuberculoid leprosy patients (12) . Thl cells participate mainly in delayed-type hypersensitivity reactions, such those observed in PB patients, and Thl clones secrete gamma interferon among other lymphokines; the role of gamma interferon in the induction of cytotoxicity is well known (37, 41) . The relative importance of CD4-or CD8-mediated cytotoxicity in the balance between protection and tissue damage in PB or MB patients remains to be established.
